Aclaris Therapeutics, Inc. - Common Stock (NQ:ACRS)

4.390 -0.020 (-0.45%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aclaris Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

ACRS stock results show that Aclaris Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Biotech’s Role in Addressing the Pancreatic Cancer Emergency

March 14, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

Via FinancialNewsMedia

Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying ↗

March 06, 2024

The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Aclaris Therapeutics: Q4 Earnings Insights ↗

February 27, 2024

Via Benzinga

The Analyst Landscape: 4 Takes On Aclaris Therapeutics ↗

January 11, 2024

Via Benzinga

Breaking Down Aclaris Therapeutics: 6 Analysts Share Their Views ↗

December 18, 2023

Via Benzinga

Aclaris Therapeutics Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

December 18, 2023

Via Benzinga

The Latest Analyst Ratings for Aclaris Therapeutics ↗

November 14, 2023

Via Benzinga

Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades ↗

January 22, 2024

HC Wainwright downgrades Aclaris Therapeutics post Phase 2b results of ATI-1777 for atopic dermatitis. Analyzing efficacy, commercial prospects, and competitive landscape.

Via Benzinga

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 22, 2024

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the...

Via Benzinga

Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket ↗

January 22, 2024

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 16, 2024

Via Benzinga

Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today? ↗

January 16, 2024

Aclaris Therapeutics leadership changes and strategic review. Preliminary unaudited data as of Dec 31, 2023, reveals approximately $182M in cash, cash equivalents, and marketable securities. Aclaris...

Via Benzinga

Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations ↗

January 10, 2024

Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to

Via Benzinga

Crude Oil Falls 1%; Amarin Shares Spike Higher ↗

January 10, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The...

Via Benzinga

Topics Stocks

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 10, 2024

Via Benzinga

Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week ↗

January 10, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P...

Via Benzinga

Topics Stocks

Aclaris Therapeutics Shares Fall On Mixed Results From Mid-Stage Eczema Trial ↗

January 10, 2024

Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to

Via Benzinga

Dow Surges 100 Points; PriceSmart Earnings Top Views ↗

January 10, 2024

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 37,627.83 while the NASDAQ rose...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 10, 2024

Via Benzinga

Inflammatory Disease Focused Aclaris Therapeutics Reduces Staff After Failed Psoriatic Arthritis Study ↗

December 20, 2023

Aclaris Therapeutics Inc (NASDAQ: ACRS) announced the publication of the Phase 2a trial results of ATI-1777 in moderate to severe atopic dermatitis (AD) in the peer-reviewed

Via Benzinga

Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

December 06, 2023

Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 14, 2023

Via Benzinga

Crude Oil Gains Over 1%; US Budget Deficit Narrows For October ↗

November 13, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.16% to 34,337.33 while the NASDAQ fell 0.11% to 13,783.41. The S&P 500...

Via Benzinga

Topics Stocks

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 13, 2023

Via Benzinga

Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher ↗

November 13, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.33% to 34,397 while the NASDAQ fell 0.06% to 13,790. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Arthritis-Focused Aclaris Therapeutics Stock Nosediving Today? ↗

November 13, 2023

Aclaris Therapeutics Inc (NASDAQ: ACRS) shares plunged after the company released topline results from a Phase 2b study of zunsemetinib (ATI-450) in subjects with moderate to

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.